StonvexLoading…
StonvexStonvexStonvexCore line items from AMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.85B | $4.64B | $4.81B | $3.91B |
Operating Income | $-17.40M | $-79.30M | $-74.30M | $-522.30M |
Net Income | $-632.40M | $-352.60M | $-396.60M | $-973.60M |
EPS (Diluted) | $-1.34 | $-1.06 | $-2.37 | $-9.29 |
Total Assets | $8.02B | $8.25B | $9.01B | $9.14B |
Total Liabilities | $9.91B | $10.01B | $10.86B | $11.76B |
Cash & Equivalents | $428.50M | $632.30M | $884.30M | $631.50M |
Free Cash Flow OCF − CapEx | $-365.90M | $-296.30M | $-440.80M | $-830.50M |
Shares Outstanding | 472.90M | 332.92M | 167.64M | 104.77M |